Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicinova (MNOV) Profit After Tax (2021 - 2025)

Medicinova (MNOV) has disclosed Profit After Tax for 7 consecutive years, with -$3.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Profit After Tax changed N/A to -$3.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$13.0 million, a N/A change, with the full-year FY2025 number at -$12.0 million, down 8.58% from a year prior.
  • Profit After Tax was -$3.8 million for Q4 2025 at Medicinova, down from -$3.1 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$187799.0 in Q1 2021 to a low of -$4.3 million in Q2 2021.
  • A 5-year average of -$2.8 million and a median of -$2.9 million in 2023 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: crashed 1703.21% in 2022, then skyrocketed 80.2% in 2023.
  • Medicinova's Profit After Tax stood at -$2.1 million in 2021, then crashed by 75.32% to -$3.7 million in 2022, then skyrocketed by 43.62% to -$2.1 million in 2023, then plummeted by 38.52% to -$2.9 million in 2024, then tumbled by 31.94% to -$3.8 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Profit After Tax are -$3.8 million (Q4 2025), -$3.1 million (Q3 2025), and -$3.3 million (Q2 2025).